1.
Zhang QY, Ye XP, Zhou Z, et al. Lymphocyte infiltration and thyrocyte destruction are driven by stromal and immune cell components in Hashimoto's thyroiditis. Nat Commun. 2022;13(1):775. doi:10.1038/s41467-022-28120-2
2.
Caturegli P, De Remigis A, Rose NR. Hashimoto thyroiditis: clinical and diagnostic criteria. Autoimmun Rev. 2014;13(4-5):391-397. doi:10.1016/j.autrev.2014.01.007
3.
Weetman AP. An update on the pathogenesis of Hashimoto's thyroiditis. J Endocrinol Invest. 2021;44(5):883-890. doi:10.1007/s40618-020-01477-1
4.
Hu X, Chen Y, Shen Y, Tian R, Sheng Y, Que H. Global prevalence and epidemiological trends of Hashimoto's thyroiditis in adults: a systematic review and meta-analysis. Front Public Health. 2022;10:1020709. doi:10. 3389/fpubh.2022.1020709
5.
Hu X, Wang X, Liang Y, et al. Cancer risk in Hashimoto's thyroiditis: a systematic review and meta-analysis. Front Endocrinol (Lausanne). 2022;13:937871. doi:10.3389/fendo.2022.937871
6.
Mikulska AA, Karazniewicz-Lada M, Filipowicz D, Ruchala M, Glówka FK. Metabolic characteristics of Hashimoto's thyroiditis patients and the role of microelements and diet in the disease management-an overview. Int J Mol Sci. 2022;23(12):6580. doi:10.3390/ijms23126580
7.
Aktas G, Sit M, Dikbas O, et al. Elevated neutrophil-to-lymphocyte ratio in the diagnosis of Hashimoto's thyroiditis. Rev Assoc Med Bras (1992). 2017;63(12):1065-1068. doi:10.1590/1806-9282.63.12.1065
8.
Bilge M, Yesilova A, Adas M, Helvaci A. Neutrophil- and platelet- to lymphocyte ratio in patients with euthyroid Hashimoto's thyroiditis. Exp Clin Endocrinol Diabetes. 2019;127(8):545-549. doi:10.1055/a-0723-3441
9.
Bozdag A, Gundogan Bozdag P. Evaluation of systemic inflammation markers in patients with Hashimoto's thyroiditis. J Int Med Res. 2024; 52(9):3000605241280049. doi:10.1177/03000605241280049
10.
Erge E, Kiziltunc C, Balci SB, et al. A novel inflammatory marker for the diagnosis of Hashimoto's thyroiditis: platelet-count-to-lymphocyte-count ratio. Diseases. 2023;11(1):15. doi:10.3390/diseases11010015
11.
Kırkgöz T, Özkan B. Could hematologic parameters have a predictive role in pediatric Hashimoto thyroiditis? J Dr Behcet Uz Child Hosp. 2022;12:159-163. doi:10.4274/buchd.galenos.2022.23590
12.
Von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Int J Surg. 2014;12(12):1495-1499. doi:10.1016/j.ijsu.2014.07.013
13.
Ralli M, Angeletti D, Fiore M, et al. Hashimoto's thyroiditis: an update on pathogenic mechanisms, diagnostic protocols, therapeutic strategies, and potential malignant transformation. Autoimmun Rev. 2020;19(10): 102649. doi:10.1016/j.autrev.2020.102649
14.
Kaur J, Jialal I. Hashimoto Thyroiditis. StatPearls. StatPearls Publishing Copyright<sup>©</sup> 2025, StatPearls Publishing LLC.; 2025.
15.
Arduc A, Aycicek Dogan B, Bilmez S, et al. High prevalence of Hashimoto's thyroiditis in patients with polycystic ovary syndrome: does the imbalance between estradiol and progesterone play a role? Endocr Res. 2015;40(4):204-210. doi:10.3109/07435800.2015.1015730
16.
Kjaergaard AD, Marouli E, Papadopoulou A, et al. Thyroid function, sex hormones and sexual function: a Mendelian randomization study. Eur J Epidemiol. 2021;36(3):335-344. doi:10.1007/s10654-021-00721-z
17.
Calcaterra V, Nappi RE, Regalbuto C, et al. Gender differences at the onset of autoimmune thyroid diseases in children and adolescents. Front Endocrinol (Lausanne). 2020;11:229. doi:10.3389/fendo.2020.00229
18.
Yang H, Xia Q, Shen Y, Chen TL, Wang J, Lu YY. Gender-specific impact of metabolic obesity phenotypes on the risk of Hashimoto's thyroiditis: a retrospective data analysis using a health check-up database. J Inflamm Res. 2022;15:827-837. doi:10.2147/jir.s353384
19.
Jayanthi R, Srinivasan AR. Sex hormone independent associations between insulin resistance and thyroid status -a gender based biochemical study on clinically euthyroid non-obese, overweight and obese type 2 diabetics. Diabetes Metab Syndr. 2019;13(3):2286-2291. doi: 10.1016/j.dsx.2019.05.017
20.
Ostrowska L, Gier D, Zysk B. The influence of reducing diets on changes in thyroid parameters in women suffering from obesity and Hashimoto's disease. Nutrients. 2021;13(3):862. doi:10.3390/nu13030862
21.
Ülker MT, Çolak GA, Baş M, Erdem MG. Evaluation of the effect of gluten-free diet and Mediterranean diet on autoimmune system in patients with Hashimoto's thyroiditis. Food Sci Nutr. 2024;12(2):1180-1188. doi:10.1002/fsn3.3833
22.
Nodehi M, Ajami A, Izad M, et al. Effects of vitamin D supplements on frequency of CD4(+) T-cell subsets in women with Hashimoto's thyroiditis: a double-blind placebo-controlled study. Eur J Clin Nutr. 2019;73(9):1236-1243. doi:10.1038/s41430-019-0395-z
23.
Taylor PN, Medici MM, Hubalewska-Dydejczyk A, Boelaert K. Hypothyroidism. Lancet. 2024;404(10460):1347-1364. doi:10.1016/s 0140-6736(24)01614-3
24.
Guldvog I, Reitsma LC, Johnsen L, et al. Thyroidectomy versus medical management for euthyroid patients with Hashimoto disease and persisting symptoms: a randomized trial. Ann Intern Med. 2019;170(7): 453-464. doi:10.7326/m18-0284
25.
Dwivedi SN, Kalaria T, Buch H. Thyroid autoantibodies. J Clin Pathol. 2023;76(1):19-28. doi:10.1136/jcp-2022-208290
26.
Walsh JP, Bremner AP, Feddema P, Leedman PJ, Brown SJ, O'leary P. Thyrotropin and thyroid antibodies as predictors of hypothyroidism: a 13-year, longitudinal study of a community-based cohort using current immunoassay techniques. J Clin Endocrinol Metab. 2010;95(3):1095-1104. doi:10.1210/jc.2009-1977
27.
Hutfless S, Matos P, Talor MV, Caturegli P, Rose NR. Significance of prediagnostic thyroid antibodies in women with autoimmune thyroid disease. J Clin Endocrinol Metab. 2011;96(9):E1466-1471. doi:10.1210/jc. 2011-0228
28.
Nishihara E, Amino N, Kudo T, et al. Comparison of thyroglobulin and thyroid peroxidase antibodies measured by five different kits in autoimmune thyroid diseases. Endocr J. 2017;64(10):955-961. doi:10. 1507/endocrj.EJ17-0164